Purchase Order HHSN302201400104P

<p>The Food and Drug Administration issued a delivery order to Metabolon, Inc., a small disadvantaged business, on August 22, 2024, with a ceiling value of $151,700 for investigation of metabolomes of plasma, serum, and urine to identify biomarkers and metabolomic signatures of drug exposure and response.</p> <p>Place of performance is Morrisville, NC. The order is firm fixed price and has an ultimate completion date of September 14, 2025.</p>

Medical Command issued a $15,520 delivery order to Metabolon, Inc. on May 15, 2026, for metabolomics analysis services, with completion by November 15, 2026. Metabolon is a self-certified small disadvantaged business specializing in metabolomic testing and research support. Place of performance is Natick, MA. The order is firm fixed price with no set-aside applied. The work involves advanced scientific analysis using ultra-high performance liquid chromatography and tandem mass spectrometry for...

The National Cancer Institute awarded a purchase order to Metabolon, Inc. for $14,200 on May 24, 2019, with completion by August 1, 2019. The order is firm fixed price with no set-aside designation. Metabolon will deliver a relative concentration profile of small-molecule entities (endogenous compounds, xenobiotics, and metabolites) extracted from 40 cell pellets and detected via the HD4 global metabolomics platform, provided as an Excel file. The awardee will supply an outline of analytical...

Metabolon, Inc. was awarded a $24,650 firm fixed price purchase order by the Department of the Interior's U.S. Geological Survey Office of Acquisitions and Grants for global metabolomics analysis services. The contract has a total small business set aside designation. Metabolon will provide specialized metabolomics analysis of samples as described in the original solicitation to support biomedical research being conducted by the agency. As a self-certified small disadvantaged business and...

This is a $24,300 firm fixed-price purchase order awarded by a civilian federal agency to Metabolon, Inc., a self-certified small disadvantaged business, for metabolite profile processing services. The contract has no set-aside designation and is scheduled for completion by November 30, 2020. Metabolon is a leading provider of specialized metabolomics services and solutions to various federal agencies, offering advanced analytical capabilities in metabolite identification and quantification. The...

Microgenics Corporation, a division of Thermo Electron Corporation, has been awarded a $10,032.50 firm fixed price delivery order contract for DRI ECSTASY PLUS 500 ML MDMA/MDA reagent by the Department of the Army Medical Command. The contract has no set-aside designation. Microgenics will provide the requested MDMA/MDA reagent to the Army Medical Command for use at its place of performance in Fremont, California. The contract is to be completed by August 31, 2020. Thermo Electron Corporation...

The Indian Health Service awarded a $26,344.36 firm fixed-price purchase order to Medtox Diagnostics, Inc. for drugs of abuse testing supplies on December 28, 2020, with an ultimate completion date of September 16, 2024. The contract, which has been closed out, was performed in Crownpoint, New Mexico and was awarded without a set-aside designation. Medtox Diagnostics, a subsidiary of Laboratory Corporation of America Holdings (LabCorp), is a manufacturer of laboratory testing products and...

<p>The National Institutes of Health Clinical Center awarded a purchase order to Metabolon, Inc. for $16,000.00 on January 18, 2019, with completion on January 18, 2020. Work is performed in Morrisville, North Carolina. The order procures metabolomics services, including advanced scientific analysis and metabolite identification using ultra-high performance liquid chromatography and tandem mass spectrometry on biological samples. Metabolon is a self-certified small disadvantaged business.</p>

Medtox Laboratories Inc., a subsidiary of Laboratory Corporation of America Holdings, was awarded a $10,133.10 firm fixed price delivery order against the Multiple Award Schedule contract vehicle. The contract calls for Medtox to provide drug profiles and supplies in support of the Lawton Indian Hospital, part of the Indian Health Service within the Department of Health and Human Services. No set-aside designation was used for this award. Performance will occur in Burlington, North Carolina as...

The National Cancer Institute awarded a $12,000 firm fixed-price purchase order to Metabolon, Inc. on June 8, 2018, with final completion on June 7, 2019. Performance is at Metabolon's facility in Morrisville, North Carolina. The order procures metabolomic analysis services, including identification and quantification of metabolites from biological samples using ultra-high performance liquid chromatography and tandem mass spectrometry. Metabolon is a self-certified small disadvantaged business.